Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 4
2001 1
2002 3
2003 1
2004 2
2005 2
2006 3
2007 1
2008 1
2009 4
2010 2
2011 1
2012 1
2014 1
2016 2
2017 6
2018 1
2019 3
2020 2
2021 2
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous melanoma in older patients.
Buja A, Rugge M, Trevisiol C, Zanovello A, Brazzale AR, Zorzi M, Vecchiato A, Del Fiore P, Tropea S, Rastrelli M, Rossi CR, Mocellin S. Buja A, et al. Among authors: trevisiol c. BMC Geriatr. 2024 Mar 6;24(1):232. doi: 10.1186/s12877-024-04806-8. BMC Geriatr. 2024. PMID: 38448833 Free PMC article.
State of the art and trends of circulating cancer biomarkers.
Gion M, Trevisiol C, Fabricio ASC. Gion M, et al. Among authors: trevisiol c. Int J Biol Markers. 2020 Feb;35(1_suppl):12-15. doi: 10.1177/1724600819900512. Int J Biol Markers. 2020. PMID: 32079467 Free article.
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group. Gori S, et al. Among authors: trevisiol c. Crit Rev Oncol Hematol. 2019 Aug;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. Epub 2019 May 25. Crit Rev Oncol Hematol. 2019. PMID: 31176273 Free article.
Appropriateness of tumor marker request: a case of study.
Gion M, Trevisiol C, Fabricio ASC. Gion M, et al. Among authors: trevisiol c. Ann Transl Med. 2017 Jul;5(13):274. doi: 10.21037/atm.2017.06.19. Ann Transl Med. 2017. PMID: 28758100 Free PMC article.
Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients.
Gion M, Cardinali G, Guzzinati S, Morandi P, Trevisiol C, Fabricio ASC, Rugge M, Zorzi M. Gion M, et al. Among authors: trevisiol c. Risk Manag Healthc Policy. 2022 May 19;15:1087-1100. doi: 10.2147/RMHP.S342072. eCollection 2022. Risk Manag Healthc Policy. 2022. PMID: 35615584 Free PMC article.
Overordering of tumor marker for outpatients revealed by performance indicators and the impact of a health policy intervention: An observational study using administrative records.
Gion M, De Gobbi R, Zorzi M, Carretta G, Leonardi L, Guzzinati S, Trevisiol C, Cancian M, Cardinali G, Michieletto F, Dittadi R, Fabricio ASC, Rugge M, Russo F. Gion M, et al. Among authors: trevisiol c. Int J Biol Markers. 2023 Mar;38(1):61-71. doi: 10.1177/03936155231154663. Epub 2023 Feb 28. Int J Biol Markers. 2023. PMID: 36855811 Free article.
46 results